Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS at Natera, Inc. (NTRA), sold 6,000 shares at $237.23 ($1.4M) on 2025-12-01, disclosed to the SEC on 2025-12-03.
Scheduled sale ($1.4M) by PRESIDENT, CLINICALDIAGNOSTICS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $237.23 | 749 | $178K | 12.4% |
| 2 | $237.23 | 749 | $178K | 12.4% |
| 3 | $237.77 | 250 | $59K | 4.2% |
| 4 | $237.77 | 250 | $59K | 4.2% |
| 5 | $238.24 | 1,527 | $364K | 25.5% |
| 6 | $238.24 | 1,527 |
| $364K |
| 25.5% |
| 7 | $239.53 | 474 | $114K | 7.9% |
| 8 | $239.53 | 474 | $114K | 7.9% |
| Total | $238.15 avg | 6,000 | $1.4M | 100% |
| Filing → |
| NTRA | SELL | 2026-08-05 | $906K | — | Filing → |
| NTRA | SELL | 2026-07-29 | $569K | — | Filing → |
| NTRA | SELL | 2026-07-06 | $819K | — | Filing → |